Telemedicine is not a recent activity, and the first telemedicine centre in which pharmacists were actively involved was established in the 1950s as a centre for poisoning with various poisons. Since that time, technology has improved unimaginably, with the advent of the internet also encouraging the importance and development of telemedicine, but it has been hampered by the cost of data transmissions. Today, even this economic aspect is not a primary issue in the application of telemedicine to routine clinical practice. 

In medical circles, we have become accustomed to opening an X-ray image in any computer, which many do not even consider a success of telemedicine. Having put aside the painful memories of the COVID-19 pandemic, we are positive about the computerisation of many of the processes that the pandemic is speeding up - e-prescription, e-PN.

However, on the periphery of it all, the patient has been left standing, who, while welcoming many of the changes, is questionable as to whether or not he or she is willing to participate in all the advances that telemedicine is bringing to primary health care. It was the patient that we oriented the telemedicine biomedical research towards and ascertained the patient's attunement to the use of a telemedicine approach, not only on the part of the pharmacist.